TP53 and breast carcinoma: Here, we investigated the antitumor potential of purified α-mangostin, focusing on its antimetastatic ability, in a mouse metastatic mammary cancer model carrying a p53 mutation that demonstrates a metastatic spectrum similar to that seen in human breast cancers [15-17].